Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Recurrence 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Multiple Pulmonary Nodules 1Lung Neoplasms 1Fibroadenoma 1Breast Neoplasms 1

Interventions

Exercise 8Standard of Care 5trametinib 3tislelizumab 3Radiotherapy 3Radiosurgery 3Palliative Care 3Paclitaxel 3Gemcitabine 3130-nm albumin-bound paclitaxel 3trastuzumab deruxtecan 2cemiplimab 2Therapeutics 2Surveys and Questionnaires 2Resistance Training 2Oxaliplatin 2Nivolumab 2Maintenance 2Immune Checkpoint Inhibitors 2Drug Therapy 2Cisplatin 2Carboplatin 2vedolizumab 1toripalimab 1surufatinib 1sparsentan 1sintilimab 1semaglutide 1posaconazole 1pomalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Neoplasms × Anesthesia, General × Clear all
NCT06982690 2025-05-21

Anesthesia Modality and Oncologic Outcomes in High-Risk NMIBC: A Randomized Trial

National Taiwan University Hospital

Phase NA Not yet recruiting
370 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡